Regulatory Considerations DMEG to Review Health Canada’s Draft Guidance

Thank you to the Regulatory Considerations DMEG for sharing this update. Health Canada . . .

Read More

Recent update from the regulatory landscape in clinical data management

Thank you to the Regulatory Considerations DMEG for sharing this update. On July 15 the . . .

Read More

Regulatory Considerations DMEG Update – June 2026

Please read the following update from the Regulatory Considerations DMEG:  Regulators have . . .

Read More

FDA Announces New Initiative for Real-Time Clinical Trials

The U.S. Food and Drug Administration (FDA) has announced a new initiative to support the . . .

Read More

Get to know ACDM Board Member Jennifer Duff

We caught up with one of ACDM’s new Board Members, Jennifer Duff, to learn more about her. . . .

Read More

Recent News in Regulatory Landscape

The ACDM Regulatory Considerations DMEG have kindly put together a short news piece . . .

Read More

Real-Time Clinical Data Flow: Why the FDA’s New Pilot Validates the Data Flow Modernization Agenda

Tamer Chowdhury, on behalf of ACDM Technology DMEG. On April 28, FDA Commissioner Dr. . . .

Read More

Bridging the Behaviour Gap: The Human Skills Redefining Clinical Data Management (ACDM26 Workshop Recap)

This article has been written by Gail Kniveton, who delivered the workshop “Bridging the . . .

Read More

Regulatory Considerations DMEG reviews recent MHRA regulatory updates

The ACDM Regulatory considerations DMEG Regulatory considerations reviewed several recent . . .

Read More

ACDM26 Berlin: Shaping the Future of Clinical Data Management

The ACDM Annual Conference returned to Berlin in March 2026, welcoming the global clinical . . .

Read More

Member News Update from Lab Data Solutions LLC

This news piece has been submitted by Lab Data Solutions LLC We’re Attending US Summit . . .

Read More

Welcome Veramed as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome Veramed as a . . .

Read More